Free

What, me worry?

Brightpoint (CELL) investors probaby couldn’t be happier these days. Since July, the stock has split twice. Around this time last year, the stock was trading at under a buck. Now, it’s around $27. Much of that is because business is booming in Asia, where Brightpoint has the majority of its sales. Still, poking around in the Q filed yesterday, the discussion about selling accounts receivable should stand out for investors. While it’s not always a red flag, it certainly can be because it can make cash-flow look better than it otherwise would. According to the Q, the company sold $200.4 million in receivables for the nine months ended Sept. 30, up about 1/3 from last year. Given Brightpoint’s recent history with the SEC — it paid $450,000 to settle fraud charges last month, though it did admit or deny the SEC’s allegations — the accounts receivable is certainly worth paying attention to.